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Mitochondrial pathobiology is centrally implicated in Parkinson's disease
Parkinson's disease (PD) is a debilitating movement disorder that affects about a million people in North America, and which is expected to increase as the population grows older.
Studies employing Mendelian models of parkinsonian neurodegeneration implicate an exciting convergence with mechanisms identified from studies of Parkinson's disease patient tissues and intoxication related to drug or environmental exposures [1, 2] . In short, these three major approaches to studying PD converge upon perturbations in mitochondrial structure, function and distribution [3] . There are currently no therapies to slow disease progression, although presumed loss-of-function mutations in autosomal recessive families result in accelerated disease presenting at younger ages. Thus, studying the regulation and function of the wild type gene products may yield important therapeutic insights to prevent or delay onset and progression of PD in general [4] [5] [6] [7] .
The proteins involved in autosomal recessive PD include parkin, PTEN-induced kinase 1 (PINK1), DJ-1 and ATP13A2 [8] [9] [10] [11] . Parkin is an E3 ubiquitin ligase, and impaired proteasome function has been described in sporadic PD [5, 12] . Mitochondria are central to the actions of parkinsonian toxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine (MPTP) [13] , rotenone [7] and 6-hydroxydopamine (6-OHDA) [14, 15] , and PINK1 represents the only kinase known to exhibit a canonical N-terminal mitochondrial localization signal [10] . ATP13A2 is a lysosomal ATPase, and dysregulation of macroautophagy [16] [17] [18] and chaperone-mediated autophagy [19, 20] have been shown in mutiple models of dopaminergic neuronal injury. Finally, oxidative stress has long been considered a central factor in PD mechanisms based upon human tissue studies and PD toxin models [21, 22] . Data showing that DJ-1 localizes to mitochondria during oxidative stress [6] , where it exhibits peroxiredoxin-like activity [23] , lend further support 3
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to the concept of common pathways of dopaminergic (DA) neurodegeneration that are potentially amenable to therapeutic intervention.
Mitochondrial dynamics and neuronal differentiation and function.
Due to their polarized nature, proper distribution of mitochondria within cellular subcompartments is particularly important in neurons. Mitochondrial content in neuronal processes (axons, synapses and dendrites, known collectively as neurites) plays a critical role in regulating outgrowth and synaptic remodeling into adulthood [24, 25] . Disruption of neurite remodeling and plasticity due to old age and disease likely contributes to memory loss and neurodegeneration. Interestingly, the dynamic remodeling of pre-existing mitochondria may play a more prominent role than biogenesis in regulating mitochondrial content in neurites [26, 27] .
The classic view of mitochondrial dynamics focuses upon regulation of mitochondrial fission and fusion, although several other processes also regulate the steady state morphology and distribution of mitochondria within neurons ( Figure 1 ). Mitochondrial fusion is mediated by the inner membrane protein optic atrophy 1 (Opa1) and two outer membrane mitofusins. In general, enhanced mitochondrial fusion and connectivity play critical roles in conferring resistance to many forms of cellular injury [28, 29] , potentially through enhanced respiration, enhanced calcium buffering capacity or stabilization of the mitochondrial genome [30] .
Mutations in the fusion machinery cause several forms of hereditary neurodegeneration, attesting to the importance of proper fission-fusion dynamics in neurons [31] .
Mitochondrial fission is mediated by cytosolic and outer mitochondrial membrane proteins including dynamin-related protein (Drp1) and hFis1, which mediate mechanical constriction powered by GTP hydrolysis. While Drp1-dependent mitochondrial fission can limit 4 A C C E P T E D M A N U S C R I P T
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injury associated with calcium waves [32] , fission is often associated with cell death. Fission is elicited by the PD neurotoxins 6-OHDA [33] and rotenone [34] , playing an important role in the execution of apoptosis when occurring in conjunction with Bax recruitment [35, 36] . On the other hand, a basal level of mitochondrial fission is important for cell division and mitochondrial trafficking, and dominant negative Drp1 homologues reduce both mitochondrial content and functional plasticity of synapses [25, 26] . Little is known about the posttranslational regulation of mitochondrial dynamics, although sumoylation and phosphorylation of Drp1 have been recently reported [28, 37] .
In addition to dynamic changes in mitochondrial fission/fusion and trafficking, there is growing evidence that autophagic degradation plays a major role in regulating neurite morphology and mitochondrial content. Macroautophagy involves the regulated, membranous engulfment of cytoplasmic cargo destined for lysosomal degradation [38, 39] , and represents the only major degradative pathway for organelles and insoluble proteins [40] . The autophagy machinery includes conjugating enzymes required for covalent attachment of ubiquitin-fold proteins Atg12 and Atg8/microtubule-associated light chain protein 3 (LC3) to nascent autophagic membranes [38] . RNAi knockdown of Atg conjugation components are effective at inhibiting induction of autophagy and mitophagy [16, 18] .
Mitochondrial autophagy (mitophagy) comprises an adaptive response to hypoxia, mitochondrial damage or limiting amounts of aerobic substrates in many cell types [41] .
However, in cardiac muscle and neuronal cells, which are dependent upon aerobic respiration, robust mitophagy may also prove harmful [18, 42, 43] . Autophagy induced by cerebral hypoxia exacerbates neuronal apoptosis in vivo [44, 45] . Since substantia nigra DA neurons exhibit decreased basal mitochondrial content compared to other midbrain neurons, it has been proposed 5
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that diminished reserves may render them more susceptible to compromise of mitochondrial homeostasis during PD pathogenesis [46] . We have postulated that the outcome of mitophagy induction may depend upon the ability of neurons to replace sequestered/degraded mitochondrial components with newly synthesized replacements [39] , given data suggesting deficits in nuclear import and transcription in 6-OHDA treated neuronal cells and post-mortem PD tissues [47, 48] .
Interestingly, impaired mtDNA replication has been implicated in PINK1 deficient cells [49] , although evidence of compensatory mitochondrial and antioxidant transcription have also been reported [50, 51] .
PINK1 is a novel neuroprotective kinase
PINK1 is a 581 amino acid protein with an N-terminal mitochondrial targeting signal, a putative transmembrane segment, a Ser/Thr kinase domain, and a C-terminal regulatory domain [Reviewed in [52] ]. PINK1 was originally identified as a PTEN regulated message in cancer cells, but showed no effects on cell proliferation [53] . A homozygous G309D mutation and a truncating W437X mutation were first identified in consanguineous European PD families [10] .
Subsequently, additional autosomal recessive PINK1 mutations, including heterozygote compound mutations at E240K and L489P, were identified in other PD families [54] [55] [56] [57] . The possibility of PINK1 haploinsufficiency as a risk factor in sporadic PD has also been raised [58] [59] [60] . Although meta-analysis reveals a nonsignificant odds ratio for PINK1 heterozygotes, these patients may show accelerated disease progression [61] .
Mutations in familial PINK1 involve several regions of the protein and specific effects are likely to vary depending upon the mutation (Reviewed in [52] ). PD-associated mutations in PINK1 can affect PINK1 stability and expression levels [62] , its association with heat shock [65, 66] , although neither mitochondrial import [62] nor ability to dimerize [67] appear to be affected by the point mutations. C-terminal truncations of PINK1 are likely to affect function, as in vitro kinase activity of PINK1 is regulated in different directions by portions of the C-terminal domain [65, 66] .
Overexpression of wild type PINK1 confers protection from proteasome inhibitormediated cell death [10] , a property abolished by PD-associated mutations [68] , and PINK1 is found in mitochondria involved in aggresomes [69] . Wild type, but not mutant, PINK1 protects from staurosporine-induced apoptosis [70] , although this is not seen in all systems [34] . PINK1
protects against MPTP toxicity in vivo and MPP+ toxicity in vitro [71] , and siRNA knockdown of PINK1 expression enhances susceptibility to MPP+ and rotenone [72] . Despite these striking effects on survival, few target pathways for PINK1 have been identified. PINK1 phosphorylates the mitochondrial heat shock protein 75 (also known as TNF receptor-associated protein 1) [73] and interacts with p38 MAPK in phosphorylating the mitochondrial protease HtrA2 [74] .
In addition to neuroprotection against pharmacologic injuries, PINK1 can reduce injury associated with dominant genetic PD models. Sporadic PD and autosomal dominant parkinsonism is typically characterized by Lewy bodies containing aggregated α-synuclein. In recent years, α-synuclein has also been implicated in mitochondrial degeneration, both in vitro [75] and in vivo [76] . PINK1 protects against α-synuclein-mediated retinal degeneration in Drosophila [77] . In cultured cells, a truncated mutant PINK1 exacerbates A53T α-synuclein toxicity [78] and PINK1 siRNA elicits proteasomal impairment and α-synuclein aggregation [67] . The dominant G2019S leucine rich repeat kinase 2 causes neurite degeneration through an autophagic mechanism [17] . PINK1 overexpression protects against G2019S LRRK2-mediated 7
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neurite injury (SJ Cherra & CT Chu, unpublished data), while nematode lrk-1 is necessary for expression of pink-1 null phenotypes [79] . Given the broad neuroprotective properties of PINK1 in both toxic and genetic models of parkinsonian injury, elucidating the normal function(s) of PINK1 holds much promise towards development of future therapies that will be effective in multiple forms of PD.
PINK1 is a unique kinase directly targeted to mitochondria (sometimes)
Following identification of PINK1 as a PD-associated gene, it was found to be broadly expressed in the cortex, striatum and brainstem [80] , with regulation by post-transcriptional mechanisms [81] . PINK1 represents the first kinase to exhibit a canonical mitochondrial targeting sequence.
This consists of an N-terminal amphipathic helix that is recognized by the translocase of the outer mitochondrial membrane (TOM) [82] . PINK1 colocalizes with mitochondria in cells [65] and in human brain tissues [83] , but is also present in cytosolic fractions [62, 63] . In Drosophila, the rhomboid-7 mitochondrial proteinase may be involved inprocessing both PINK1 and HtrA2/ Omi [84] .
Recent studies show that the N-terminal mitochondrial localization signal is necessary for some [68] , but not all effects of PINK1 [71] . This suggests that PINK1 neuroprotection could involve cytosolic targets even in models involving mitochondrially targeted injury. The ability to form cytosolic complexes with parkin and DJ-1, with effects on E3 ligase activity, has been recently reported [85] . On the other hand, recombinant variants of PINK1 lacking the Nterminal domain are still present in mitochondrial fractions due to binding interactions with other proteins [86] , so these studies do not negate the probability of key mitochondrial targets for PINK1.
8
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Similarly, PINK1 localization with respect to mitochondrial subcompartments is still unclear. While most studies indicate localization predominantly near the inner mitochondrial membrane [65, 73, 78, 83] , PINK1 may also associate with outer membrane fractions to a lesser extent [78] . Moreover, one study suggests that the kinase domain faces outwards from the mitochondrion through an arrested import mechanism [87] . Like other kinases [88] , it is likely that PINK1 has multiple functions in the cell involving dynamic trafficking between subcellular compartments and scaffold complexes, depending upon post-translational modifications and proteolytic processing.
One of the challenges with studying PINK1 has been difficulty detecting endogenous levels of the PINK1 protein. Thus, localization and even degree of RNAi knockdown has been estimated using overexpressed tagged recombinant PINK1. As the degree of protein overexpression cannot be estimated without a reliable measure of endogenous PINK1, it is possible that high levels of overexpression saturate transport or processing mechanisms. Using an antibody raised to the kinase domain, the major band detected in SH-SY5Y cells is a processed form that lacks both the N-and C-terminals, whereas recombinant C-terminal tagged PINK1 migrates as a full-length species that nevertheless associates with mitochondrial fractions [89] . While detection of tagged species can be markedly enhanced by proteasome inhibition in agreement with other studies [64] , such treatments have little effect on endogenous bands.
Conversely, other studies have shown that processed PINK1 is not limited to mitochondrial fractions, suggesting either efflux from mitochondria [62] or other sites of proteolytic processing.
Other considerations include non-linearity of antibody responses, observations that one antibody may preferentially recognize one processed form over another even if equivalent amounts are present, and effects of as yet uncharacterized post-translational modifications on antibody 9 A C C E P T E D M A N U S C R I P T
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avidity. It is clear that much work remains to be done to illuminate the distribution of PINK1 under different physiologic and injury states in pertinent neuronal populations.
PINK1 loss of function has major effects on mitochondrial morphology.
Regardless of the major site(s) of PINK1 function, modulating PINK1 expression shows major effects on mitochondrial morphology in Drosophila (see below) and several mammalian studies (see Table I ). Interestingly, silencing or knockout of PINK1 expression in mice does not cause neuronal cell death [90, 91] , resulting instead in decreased evoked striatal dopamine release [91] and reduced state 3 maximal respiration in the presence of ADP [92] . Cortical regions are less susceptible to these changes, but these differences can be overcome by H 2 O 2 or heat shock, suggesting that the mice are well compensated for developmental absence of PINK1.
Drosophila studies show flight muscle degeneration accompanied by markedly swollen and enlarged mitochondria. Notably, PINK1 and parkin flies show similar phenotypes. While parkin overexpression reverses effects of PINK1 loss-of-function on mitochondrial morphology, the converse was not observed, suggesting that parkin functions downstream of PINK1 [93] [94] [95] .
The ability of parkin overexpression to correct morphologic effects of PINK1 deficiency has also been observed in mammalian cells [89, 96] . Assuming that parkin overexpression acts to directly reverse the deficit left by reduced PINK1 function, the simplest model places parkin as a mediator of PINK1 mitoprotection (Fig. 2, top) , although other potential mechanisms are also compatible with the data (Fig. 2, bottom and legend) .
Additional studies supporting a direct relationship between PINK1 and parkin include observations that a parkin peptide can be phosphorylated by ∆N-PINK1 in vitro [97] and demonstrating physical interaction between overexpressed PINK1 and parkin in the cytosol [85, 10 A C C E P T E D M A N U S C R I P T [34, 89, 96] appear to support opposite conclusions in the fission-fusion balance.
In PINK1 deficient Drosophila, GFP-tagged mitochondria in longitudinal flight muscle sections show a dishomogeneous distribution with significant clumping that is distinct from the clearly fissioned appearance elicited by knockdown of Marf (Mfn homolog) [103] . Surprisingly, immunostaining of GFP-tagged mitochondria in DA neuron whole mount sections show similar mitochondrial aggregation in both dPINK1 deficient and dPINK1 overexpressing flies [100] .
However, the mechanisms may be different as analysis of cultured Drosophila neurons, S2R
cells and COS cells reveal that more PINK1 deficient cells are scored as cells with elongated profiles compared to dPINK1 overexpressing cells [100] . In Drosophila systems, molecular manipulations to increase fission or decrease fusion protected against muscle degeneration, mitochondrial swelling and loss of brain DA levels [100, 101, 103] . These include providing an Drp1 suppresses the effects of PINK1 overexpression in the eye [101] , and exacerbated injury in PINK1 deficient flies. Assuming that the effects of manipulating mitochondrial fission-fusion machinery directly reverses the effects of insufficient PINK1, these data suggest that the normal function of PINK1 may be to promote fission [100, 101] . Alternatively, data in Drosophila muscle and testes suggest that the effects of PINK1 are not mediated by a direct linear relationship with Drp1, as the mitochondrial phenotypes are distinct and a modest deficit in Drp1 causes lethality in PINK1 null flies [103] . As discussed below, the effects of Drp1 manipulation may also be compatible with modulation of a compensatory mechanism that protects from the effects of PINK1 deficiency. (as a positive control for fusion) [89] . Ultrastructural analysis of several independent PINK1
knockdown cell lines showed a mixture of small fragmented profiles and large rounded, pale profiles, both with diminished cristae density. The appearance of larger diameter profiles has 12 
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also been described in aging PINK1 KO mice [92] and in cells co-expressing mutant α-synuclein and truncated PINK1 [78] . Confocal microscopy with 3-D reconstruction show that irregardless of diameter, mitochondrial fragments are isolated from each other, consistent with a fissiondependent process [89] . In contrast, overexpression of PINK1 results in a more interconnected network. Finally, live cell imaging was used to demonstrate that PINK1 deficient cells show reductions in the mobile fraction of mito-YFP, consistent with reduced interconnectivity [34] . In light of recent reports of PINK1 associating with mitochondrial adapters for microtubule dependent transport [86] , this data could also be consistent with reduced overall mitochondrial mobility. Irregardless, rates of mitochondrial fusion were decreased in PINK1 deficient cells when assayed using photoactivated mito-GFP [34] . Taken together, these studies demonstrate a shift in the fission-fusion balance to favor Drp1-dependent fission in PINK1 deficient cells.
In human neuronal cells, the mitochondrial fragmentation phenotype is suppressed by dominant negative Drp1 [89] , Drp1 knockdown, or Opa1/Mfn2 overexpression [34] .
Overexpression of Drp1 promotes further fragmentation. Furthermore, PINK1 knockdown cells exhibit decreased phosphorylation of Drp1 at S637 through activation of calcineurin phosphatase activity [34] , while PINK1 overexpressing cells exhibit Drp1 2D-gel mobility consistent with higher phosphorylation states (SJ Cherra & CT Chu, unpublished data). Because Drp1 phosphorylation at S637 inhibits its ability to mediate fission [104] , these data are consistent with a role for PINK1 in suppressing fission. Interestingly, suppressing Drp1 activity exacerbated cellular injury in the setting of PINK1 deficiency [89] , in agreement with Drosophila studies, despite reversing the mitochondrial morphology changes. Again, these data implicate fission as a response to injury elicited by PINK1 deficiency. 13 
Alternative models for PINK1-parkin interactions and mitochondrial regulation.
While direct studies of mitochondrial fission and fusion kinetics may help resolve some issues, it is important to recognize that fission and fusion are not the only modulators of the steady state appearance of the mitochondrial network (Fig. 1) . Selective clearance of smaller somatic mitochondrial fragments through either axonal transport or autophagic degradation, or alterations in delivery of newly synthesized mitochondrial components, can each affect the distribution of elongated or punctate mitochondria. A recent pair of studies that together suggest an alternative model for PINK1-parkin interactions (Fig. 2 bottom) , may also partially resolve some of the controversies associated with effects of Drp1 modulation between Drosophila and human neuronal lines.
It has been elegantly demonstrated that parkin regulates not only proteasomal degradation, but is recruited to chemically depolarized mitochondria where it promotes their degradation through autophagy [105] . While autophagy has been traditionally viewed as a nonselective bulk housekeeping process, recent work in injury and disease models support the concept that selective mechanisms of targeted degradation must also exist. For mitochondrial autophagy, eat-me signals may include decreased membrane potential [41, 105, 106] , targets of mitogen activated protein kinase/extracellular signal regulated protein kinase activity [18] , or lipid oxidation [107] . Interestingly, given the E3 ligase function of parkin, certain forms of ubiquitination may also be involved in autophagy regulation [108] .
If parkin rescues from PINK1 deficiency by reconstituting a downstream function of PINK1, it would be logical to surmise that PINK1 may also function to promote clearance of damaged mitochondria. Instead, we found the opposite: wild type PINK1 suppresses injuryinduced autophagy while PINK1 deficient lines showed induction of autophagy and 14
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mitochondrial degradation [89] . Further investigation revealed that parkin overexpression complements the effects of PINK1 knockdown in human neuronal cells by further enhancing autophagic clearance of mitochondria isolated by fission [89] . Also, an intact autophagy machinery is essential for parkin-mediated protection against cell death in PINK1 deficient cells (RK Dagda & CT Chu, unpublished data). These studies indicate that PINK1 and Parkin can promote a similar steady state phenotype of healthy, elongated mitochondrial networks by acting at different ends of the process, with PINK1 maintaining mitochondrial health and Parkin eliminating damaged mitochondria. Similarly, the ability of fission mediators to rescue against injury in Drosophila PINK1 mutants, may relate to enhancing the isolation and clearance of damaged mitochondria (Fig. 2, bottom) . Undoubtedly both fission and fusion are activated as an injury response (Fig. 1) , with the steady state outcome on mitochondrial morphology dependent upon cell type-and context-dependent differences in compensatory reserve and susceptibility to injury.
A third model must also be considered, as it is possible that PINK1 and parkin regulate a common process or outcome through distinct mechanisms. For example, PINK1 [49] and parkin [109] may be implicated in mitochondrial biogenesis through different pathways. Furthermore, although PINK1 does not rescue parkin null phenotypes in Drosophila, parkin can still function upstream of PINK1 by modulating its processing and subcellular distribution [63] . These models are not mutually exclusive, and it is likely that multiple levels of interaction exist depending upon the particular process regulated by PINK1.
Towards a unifying model of PINK1 deficiency studies.
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If the primary role of PINK1 is to maintain healthy mitochondrial networks, with perturbations in mitochondrial dynamics occurring secondary to injury, what then contributes to mitochondrial or cellular injury? The final portion of this review will focus upon data implicating 1) abnormal cristae structure and function, 2) calcium dysregulation, and 3) oxidative stress, each of which may provide signals to trigger mitochondrial remodeling and autophagy.
Abnormal cristae structure and membrane depolarization have been consistently described in all mammalian culture studies of PINK1 deficiency ( Table I ). Given that cristae are important for expanding the surface area of the inner mitochondrial membrane available for mitochondrial respiration, it is likely that these structural and functional alterations are linked.
PINK1 may play a primary role in modulating the functional morphology of cristae, given its recently reported association with mitofilin [86] . These changes are unlikely to occur purely as a nonselective consequence of PINK1 deficient injury, as overexpression of PINK1 causes markedly increased cristae density without eliciting an autophagic injury response [89] . The mechanisms for abnormal electron transport chain function are still being elucidated, and may include substrate limitation [110] or direct effects on mitochondrial complex I function [111] , although no consistent change in expression of mitochondrial electron transport complex components has been reported ( Table I ). Given that changes in mitochondrial membrane potential play important normal roles in regulating axonal transport [112, 113] , mitophagy or apoptosis [114] , additional work on the role of PINK1 in modulating membrane potential may yield new therapeutic directions.
Mitochondrial calcium dysregulation may play a key role in PINK1 deficient cells [110] and in a combined mutant α-synuclein and mutant PINK1 model [78] . Under normal circumstances, mitochondria play an important role in rapid buffering of cytosolic calcium, 16 
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
taking up calcium into the matrix through a membrane potential-dependent uniporter [115] . An unidentified sodium-calcium antiporter than releases calcium back into the cell, preventing saturation of this buffering system. In PINK1 deficient human and mouse neurons, defective antiporter function results in elevated basal mitochondrial calcium levels and impaired buffering capacity [110] ; inhibiting calcium uptake into mitochondria protects against effects of overexpressed W437X PINK1 and A53T α-synuclein in rat neuroblastoma cells [78] . Among effects of elevated cytosolic calcium are activation of NADPH oxidase [110] and calcineurin, which promotes fission in PINK1 knockdown cells [34] . Antioxidants reverse glucose uptake deficits and restore function of the electron transport chain [34] . Interestingly, chronic lysosomal dysfunction results in accumulation of mitochondria with calcium buffering deficits and enhanced sensitivity to calcium mobilizing injuries [116] . Likewise, mitochondrial fission, which exacerbates cell death due to Drp1-dependent recruitment of Bax, protects against injuries involving propagating mitochondrial calcium waves [32] . Given that fission plays a protective role in PINK1 deficient cells [89, 100, 101, 103] , these observations provide additional indirect support to the calcium dysregulation model for PINK1 deficiency.
Oxidative stress has been implicated in eye degeneration caused by dPINK1 inactivation in fruit flies [117] and in several mammalian neuronal systems [49, 51, 89] . While PINK1 has been implicated in a FOXO3a-mediated ROS defense pathway [118] , increased electron leakage from dysfunctional respiration or calcium-mediated activation of NADPH oxidases could contribute to ROS generation in PINK1 deficient cells. ROS-mediated damage to nearby respiratory components and/or mtDNA could in turn set up a damaging positive feedback loop to further amplify injury. Whether ROS is a primary or secondary event, these species clearly contribute to injury. Although there is little evidence of oxidative injury in PINK1 knockout 17 
mice other than aconitase inactivation [113] , antioxidant enzymes and pharmaceutical agents confer significant protection against several alterations observed in PINK1 deficient Drosophila [117] and human cells, including diminished membrane potential [89, 110] .
It may be worth separating potential signaling functions of reactive oxygen species from pathologic levels of oxidative stress. For instance, reversible redox inactivation of autophagy proteins that remove LC3 from membranes may function as part of a physiologic regulatory system that allows initiation of starvation-induced autophagy [119] . Much higher levels of mitochondrial ROS, however, may result in overactivation of autophagy through robust mitochondrial ERK activation [15, 18] or loss of physiologic feedback mechanisms involving beclin 1 [120] . While autophagy is cytoprotective in the context of PINK1 deficiency, beclin 1 independent autophagy contributes to neurite retraction in the MPP+ and G2019S LRRK2 models [16, 17] . As with fission/fusion and other potential therapeutic targets, either insufficient or excess stimulation may prove harmful unless properly balanced [39] .
Conclusions
Mitochondrial fragmentation, cristae loss and mitophagy have been observed in human neurodegenerative diseases [121, 122] , suggesting that perturbations in fission-fusion homeostasis and autophagy could contribute to neuritic/synaptic dysfunction and neurodegeneration in PD. Current data in models of autosomal recessive PARK6 neurodegeneration suggest that aberrant cristae/inner membrane function, calcium dysregulation and oxidative stress trigger a series of pathogenic as well as compensatory pathways.
Coordinated activation of mitochondrial fission and autophagy function to isolate dysfunctional 18 A C C E P T E D M A N U S C R I P T
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mitochondria, limiting cell death, while fusion may also be activated to facilitate repair and mtDNA stabilization [30] .
Complementation of PINK1 deficient states may be mediated by 1) restoring pathways dependent upon PINK1 function, 2) reversing pathologic pathways activated in its absence, or 3)
facilitating success of compensatory mechanisms. Given that stimulating fission or autophagy can be beneficial in some contexts and harmful in others, additional studies are warranted to distinguish cause from correlation, and factors that determine success of a given compensatory or protective response. Both direct and indirect effects of altered PINK1 kinase activity and/or localization could form valid targets for therapeutic modulation. Understanding pathways of injury and compensation are important therapeutically whether or not they represent direct kinase substrates, as there are multiple mechanisms to achieve a common phenotype of a healthy neuronal mitochondrial network. Given the broad neuroprotective properties of PINK1 in both toxic and genetic models of parkinsonian injury, elucidating the normal function(s) of PINK1 offers exciting promise for therapies effective in multiple forms of PD.
ACKNOWLEDGMENTS
The authors' research is supported by the National Institutes of Health (AG026389, NS053777, DC009120). 2) An alternative model is suggested by data showing opposite effects of PINK1 and parkin activities on autophagy/mitophagy [89] . PINK1 maintains healthy mitochondrial networks regulated by a steady state fission-fusion balance, and in the absence of damage, there is no stimulus to induce autophagy. In PINK1 deficient cells, fission and autophagy are coordinately upregulated to isolate damaged and often swollen segments of mitochondria, preventing propagation of calcium waves and release of oxidants and other death mediators.
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
Parkin overexpression augments selective clearance of depolarized mitochondria [105] . Thus, PINK1 and Parkin promote a similar steady state phenotype of healthy mitochondrial networks by acting at different ends of the process, with PINK1 maintaining mitochondrial health and Parkin eliminating damaged mitochondria. Experimentally increasing Drp1 indirectly protects against cell injury by further enhancing the compensatory fission-autophagy process (rather than by restoring a normal PINK1 function), while knockdown of Drp1 function and increased Opa serve to exacerbate injury.
These two models are not mutually exclusive, and there is at least one other model in which both proteins may affect a similar process through different mechanisms. For example, both Parkin and PINK1 may function to enhance mitochondrial biogenesis [49, 109] , but Parkin does not rescue the effects of PINK1 deficiency in this context.
